Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | Bri3bp (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BRI3BP mRNA] | CTD | PMID:31150632 | (1->4)-beta-D-glucan | multiple interactions | ISO | Bri3bp (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BRI3BP mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | increases expression | ISO | Bri3bp (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of BRI3BP mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | multiple interactions | ISO | Bri3bp (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BRI3BP mRNA | CTD | PMID:17942748 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol binds to ESR2 protein] which results in increased expression of BRI3BP mRNA | CTD | PMID:20404318 | 17beta-estradiol | multiple interactions | ISO | Bri3bp (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of BRI3BP mRNA | CTD | PMID:26496021 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of BRI3BP mRNA | CTD | PMID:23019147 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:19095052 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Bri3bp (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BRI3BP mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Bri3bp (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BRI3BP mRNA | CTD | PMID:21215274 | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of BRI3BP mRNA | CTD | PMID:21179406 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Bri3bp (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of BRI3BP mRNA | CTD | PMID:20188158 | 3-methylcholanthrene | increases expression | ISO | Bri3bp (Mus musculus) | 6480464 | Methylcholanthrene results in increased expression of BRI3BP mRNA | CTD | PMID:25926378 | 6-propyl-2-thiouracil | increases expression | ISO | Bri3bp (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of BRI3BP mRNA | CTD | PMID:30047161 | aflatoxin B1 | decreases expression | ISO | Bri3bp (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of BRI3BP mRNA | CTD | PMID:19770486 | amitrole | increases expression | ISO | Bri3bp (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of BRI3BP mRNA | CTD | PMID:30047161 | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of BRI3BP mRNA | CTD | PMID:33212167 | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of BRI3BP gene | CTD | PMID:25304211 | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of BRI3BP gene | CTD | PMID:25304211 | benzo[a]pyrene | decreases expression | ISO | Bri3bp (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of BRI3BP mRNA | CTD | PMID:19770486 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of BRI3BP promoter | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | increases expression | ISO | Bri3bp (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of BRI3BP mRNA | CTD | PMID:19850644 | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Bri3bp (Mus musculus) | 6480464 | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of BRI3BP mRNA] | CTD | PMID:19850644 | bisphenol A | multiple interactions | ISO | Bri3bp (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of BRI3BP mRNA | CTD | PMID:26496021 | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of BRI3BP gene | CTD | PMID:31601247 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of BRI3BP mRNA | CTD | PMID:30903817 | bisphenol A | increases expression | ISO | Bri3bp (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of BRI3BP mRNA | CTD | PMID:25181051 | carbon nanotube | increases expression | ISO | Bri3bp (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in increased expression of BRI3BP mRNA | CTD | PMID:25554681 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to BRI3BP gene] | CTD | PMID:28238834 | clotrimazole | increases expression | ISO | Bri3bp (Rattus norvegicus) | 6480464 | Clotrimazole results in increased expression of BRI3BP mRNA | CTD | PMID:30047161 | copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of BRI3BP mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of BRI3BP mRNA | CTD | PMID:20971185 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of BRI3BP mRNA | CTD | PMID:19549813 | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRI3BP mRNA | CTD | PMID:19167446 | dimethylarsinic acid | multiple interactions | ISO | Bri3bp (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BRI3BP mRNA | CTD | PMID:34876320 | dioxygen | decreases expression | EXP | | 6480464 | Oxygen deficiency results in decreased expression of BRI3BP mRNA | CTD | PMID:26516004 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of BRI3BP mRNA | CTD | PMID:29803840 | endosulfan | increases expression | ISO | Bri3bp (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of BRI3BP mRNA | CTD | PMID:29391264 | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRI3BP mRNA | CTD | PMID:19167446 | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BRI3BP mRNA | CTD | PMID:27188386 | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of BRI3BP mRNA | CTD | PMID:26272509 and PMID:27188386 | inulin | multiple interactions | ISO | Bri3bp (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of BRI3BP mRNA | CTD | PMID:36331819 | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of BRI3BP protein | CTD | PMID:32959892 | lead(0) | decreases expression | EXP | | 6480464 | Lead results in decreased expression of BRI3BP mRNA | CTD | PMID:19921347 | methimazole | increases expression | ISO | Bri3bp (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of BRI3BP mRNA | CTD | PMID:30047161 | methylarsonic acid | multiple interactions | ISO | Bri3bp (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BRI3BP mRNA | CTD | PMID:34876320 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of BRI3BP mRNA | CTD | PMID:28001369 | ozone | multiple interactions | ISO | Bri3bp (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of BRI3BP mRNA | CTD | PMID:34911549 | panobinostat | increases expression | EXP | | 6480464 | panobinostat results in increased expression of BRI3BP mRNA | CTD | PMID:26272509 | paracetamol | affects expression | ISO | Bri3bp (Mus musculus) | 6480464 | Acetaminophen affects the expression of BRI3BP mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of BRI3BP mRNA | CTD | PMID:22230336 | paraquat | increases expression | ISO | Bri3bp (Rattus norvegicus) | 6480464 | Paraquat results in increased expression of BRI3BP mRNA | CTD | PMID:32680482 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Bri3bp (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BRI3BP mRNA more ... | CTD | PMID:36331819 | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of BRI3BP protein | CTD | PMID:26879310 | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of BRI3BP mRNA | CTD | PMID:33325755 | phytoestrogen | multiple interactions | EXP | | 6480464 | [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of BRI3BP mRNA | CTD | PMID:33325755 | pirinixic acid | increases expression | ISO | Bri3bp (Mus musculus) | 6480464 | pirinixic acid results in increased expression of BRI3BP mRNA | CTD | PMID:18301758 and PMID:20813756 | resveratrol | increases expression | ISO | Bri3bp (Mus musculus) | 6480464 | resveratrol results in increased expression of BRI3BP protein | CTD | PMID:25505154 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenate | multiple interactions | ISO | Bri3bp (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BRI3BP mRNA | CTD | PMID:34876320 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of BRI3BP mRNA | CTD | PMID:28595984 and PMID:34032870 | sodium arsenite | multiple interactions | ISO | Bri3bp (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BRI3BP mRNA | CTD | PMID:34876320 | sulfadimethoxine | increases expression | ISO | Bri3bp (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of BRI3BP mRNA | CTD | PMID:30047161 | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of BRI3BP mRNA | CTD | PMID:31533062 | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of BRI3BP mRNA | CTD | PMID:31758290 | tetrachloromethane | multiple interactions | ISO | Bri3bp (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BRI3BP mRNA] | CTD | PMID:31150632 | tetrachloromethane | increases expression | ISO | Bri3bp (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of BRI3BP mRNA | CTD | PMID:31150632 | titanium dioxide | increases expression | ISO | Bri3bp (Rattus norvegicus) | 6480464 | titanium dioxide results in increased expression of BRI3BP mRNA | CTD | PMID:30012374 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of BRI3BP mRNA | CTD | PMID:24935251 and PMID:26272509 | trimellitic anhydride | increases expression | ISO | Bri3bp (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of BRI3BP mRNA | CTD | PMID:19042947 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BRI3BP mRNA | CTD | PMID:27188386 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of BRI3BP mRNA | CTD | PMID:23179753 more ... | |